Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node–only Disease

作者：Joaquim Bellmunt, Thomas Powles, Se Hoon Park, Éric Voog, Begoña P. Valderrama, Howard Gurney, Anders Ullén, Yohann Loriot, Srikala S. Sridhar, Norihiko Tsuchiya, Cora N. Sternberg, Jeanny B. Aragon‐Ching, Daniel P. Petrylak, Miguel Á. Climent Durán, Karin Tyroller, Jason Hoffman, Natalia Jacob, Petros Grivas, Shilpa Gupta · 发表于：European Urology · 年份：2025 · DOI：10.1016/j.eururo.2025.05.017 · 被引用次数：7 · 研究领域：Bladder and Urothelial Cancer Treatments、Urinary and Genital Oncology Studies、Esophageal Cancer Research and Treatment